Mobile

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Two-Phase Crossover Study of the Metabolic Impact of Tenofovir Disoproxil Fumarate on HIV 1 Seronegative Healthy Adult Males

Update Il y a 5 ans
Reference: EUCTR2004-005083-25

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To assess the impact on insulin sensitivity (determined by peripheral glucose uptake using a euglycaemic clamp) of the administration of tenofovir DF compared with placebo for two weeks in HIV 1 seronegative healthy male volunteers.

Inclusion criteria

  • Human Immunodeficiency Virus (HIV-1) Infection

Links